FDA Inspection 861652 — Novartis Pharma AG
The FDA completed an inspection of Novartis Pharma AG on December 5, 2013 in Basel. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 5, 2013
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Basel (Switzerland)